Case Study: Top-10 Pharmaceutical Manufacturing Company achieves optimized rebate investments and a ~5 percentage-point discount reduction with IntegriChain

Optimizing Rebate Investments with PBMs & HMOs

Top-10 Pharmaceutical Manufacturing Company, a division of a top-10 pharma manufacturer, faced highly subjective managed care pricing decisions driven by limited, inaccurate data, no rebate system, and siloed internal processes. IntegriChain was engaged to integrate managed care data and apply its business tool and Rational Pricing methodology to bring fact-based analytics to rebate investment decisions.

IntegriChain analyzed roughly two years of internal Excel-based data and third-party claims across more than 12 strategic PBMs/HMOs, manually loading and validating the information in its business tool, prioritizing accounts by objective business variables and implementing Rational Pricing. The engagement produced new SOPs and best-practice contract structures, identified underperforming accounts, and reduced the average discount by just under 5 percentage points over about three years with marginal to no impact on market share, streamlining managed-care pricing decisions.